BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11590908)

  • 21. CD56 expression in benign and malignant thyroid lesions.
    Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
    Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
    Haber RS; Weiser KR; Pritsker A; Reder I; Burstein DE
    Thyroid; 1997 Jun; 7(3):363-7. PubMed ID: 9226204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fine-needle aspiration biopsy in the management of thyroid nodules.
    Miller TR; Abele JS; Greenspan FS
    West J Med; 1981 Mar; 134(3):198-205. PubMed ID: 7269555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases.
    Aratake Y; Kotani T; Tamura K; Araki Y; Kuribayashi T; Konoe K; Ohtaki S
    Am J Clin Pathol; 1991 Sep; 96(3):306-10. PubMed ID: 1715126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
    Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
    Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of CD56 and nm23 markers in papillary thyroid carcinoma.
    Shahebrahimi K; Madani SH; Fazaeli AR; Khazaei S; Kanani M; Keshavarz A
    Indian J Pathol Microbiol; 2013; 56(1):2-5. PubMed ID: 23924549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of immunoperoxidase staining of thyroglobulin in fine needle aspiration cytology of thyroid diseases.
    Tung CC; Chang TC; Hsieh HC
    Acta Cytol; 1995; 39(3):396-401. PubMed ID: 7539201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine needle aspiration biopsy of thyroid nodules.
    Prinz RA; O'Morchoe PJ; Barbato AL; Braithwaite SS; Brooks MH; Emanuele MA; Lawrence AM; Paloyan E
    Ann Surg; 1983 Jul; 198(1):70-3. PubMed ID: 6859995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of cytokeratin-19, galectin-3, and Hector Battifora mesothelial-1 in the diagnosis of benign and malignant thyroid nodules.
    Cui W; Sang W; Zheng S; Ma Y; Liu X; Zhang W
    Clin Lab; 2012; 58(7-8):673-80. PubMed ID: 22997967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic identification of new biomarkers and application in thyroid cytology.
    Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ
    Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.
    Komatsu M; Hanamura N; Tsuchiya S; Seki T; Kuroda T
    Radiat Med; 1994; 12(6):293-9. PubMed ID: 7724824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine needle aspiration of the thyroid gland.
    Settakorn J; Chaiwun B; Thamprasert K; Wisedmongkol W; Rangdaeng S
    J Med Assoc Thai; 2001 Oct; 84(10):1401-6. PubMed ID: 11804248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine needle aspiration and core needle biopsy techniques in the diagnosis of nodular thyroid pathologies.
    Pisani T; Bononi M; Nagar C; Angelini M; Bezzi M; Vecchione A
    Anticancer Res; 2000; 20(5C):3843-7. PubMed ID: 11268465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
    Ha EJ; Baek JH; Lee JH; Song DE; Kim JK; Shong YK; Hong SJ
    Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
    Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B
    Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.